Martin Gaynor: "Inside the ‘Black Box’ of Health Care Spending Data?" 2.18.16reportingonhealth
Martin Gaynor's slides from the Center for Health Journalism webinar "Inside the ‘Black Box’ of Health Care Spending Data," 2.18.16
http://www.centerforhealthjournalism.org/content/inside-black-box-health-care-spending-data
Zack Cooper: "Inside the ‘Black Box’ of Health Care Spending Data?" 2.18.16reportingonhealth
Zack Cooper's slides from the Center for Health Journalism webinar "Inside the ‘Black Box’ of Health Care Spending Data," 2.18.16
http://www.centerforhealthjournalism.org/content/inside-black-box-health-care-spending-data
Pacing Volume-to-Value Transition and The ROI of Avoiding Antibiotic Overuse PYA, P.C.
PYA Principals Scott Clay and J. Michael Keegan, MD, will join forces to present “Hot Topics: Pacing Volume-to-Value Transition” and “The ROI of Avoiding Antibiotic Overuse” at the AlaHA Annual Meeting, June 8-11, 2016. The two-part presentation first will explore volume- to value-based reimbursement, and how the pace of change is unique to each organization. The presentation will introduce a strategic framework to establish and communicate a pace of change befitting various organizations, explaining:
How government policies “set the floor” on the degree of change requested.
How to determine the pace of change in your market.
How to identify your organization’s current position and culture in relation to value-based payment models.
How to set and communicate the pace of transition consistent with your market and your organization’s culture.
The second portion of the presentation will focus on the importance of antibiotic stewardship programs (ASP) for population health. The presentation will explain:
Why the Centers for Medicare & Medicaid Services is proposing a requirement that hospitals implement ASPs to stem the rise of resistant bacteria.
Why PYA is invested in offering hospitals a proven program for improving patient safety while saving costs.
What constitutes a successful ASP.
Sabriya Rice: "Does ‘Pay for Performance’ Work?" 6.28.16reportingonhealth
Sabriya Rice's slides from the Center for Health Journalism webinar "Does ‘Pay for Performance’ Work?" 6.28.16
http://www.centerforhealthjournalism.org/content/does-pay-performance-work
Larry Levitt: "Out of Pocket: Surprise Costs After Health Reform," 10.29.15reportingonhealth
Larry Levitt's presentation from "Out of Pocket: Surprise Costs After Health Reform," 10.29.15
http://www.reportingonhealth.org/content/out-pocket-surprise-costs-after-health-reform
Meghan Hoyer: "Will the Silver Tsunami Send Medicare into the Red?" 12.17.15reportingonhealth
Meghan Hoyer's slides from the Center for Health Journalism webinar "Will the Silver Tsunami Send Medicare into the Red?" 12.17.15
http://www.centerforhealthjournalism.org/content/will-silver-tsunami-send-medicare-red
Martin Gaynor: "Inside the ‘Black Box’ of Health Care Spending Data?" 2.18.16reportingonhealth
Martin Gaynor's slides from the Center for Health Journalism webinar "Inside the ‘Black Box’ of Health Care Spending Data," 2.18.16
http://www.centerforhealthjournalism.org/content/inside-black-box-health-care-spending-data
Zack Cooper: "Inside the ‘Black Box’ of Health Care Spending Data?" 2.18.16reportingonhealth
Zack Cooper's slides from the Center for Health Journalism webinar "Inside the ‘Black Box’ of Health Care Spending Data," 2.18.16
http://www.centerforhealthjournalism.org/content/inside-black-box-health-care-spending-data
Pacing Volume-to-Value Transition and The ROI of Avoiding Antibiotic Overuse PYA, P.C.
PYA Principals Scott Clay and J. Michael Keegan, MD, will join forces to present “Hot Topics: Pacing Volume-to-Value Transition” and “The ROI of Avoiding Antibiotic Overuse” at the AlaHA Annual Meeting, June 8-11, 2016. The two-part presentation first will explore volume- to value-based reimbursement, and how the pace of change is unique to each organization. The presentation will introduce a strategic framework to establish and communicate a pace of change befitting various organizations, explaining:
How government policies “set the floor” on the degree of change requested.
How to determine the pace of change in your market.
How to identify your organization’s current position and culture in relation to value-based payment models.
How to set and communicate the pace of transition consistent with your market and your organization’s culture.
The second portion of the presentation will focus on the importance of antibiotic stewardship programs (ASP) for population health. The presentation will explain:
Why the Centers for Medicare & Medicaid Services is proposing a requirement that hospitals implement ASPs to stem the rise of resistant bacteria.
Why PYA is invested in offering hospitals a proven program for improving patient safety while saving costs.
What constitutes a successful ASP.
Sabriya Rice: "Does ‘Pay for Performance’ Work?" 6.28.16reportingonhealth
Sabriya Rice's slides from the Center for Health Journalism webinar "Does ‘Pay for Performance’ Work?" 6.28.16
http://www.centerforhealthjournalism.org/content/does-pay-performance-work
Larry Levitt: "Out of Pocket: Surprise Costs After Health Reform," 10.29.15reportingonhealth
Larry Levitt's presentation from "Out of Pocket: Surprise Costs After Health Reform," 10.29.15
http://www.reportingonhealth.org/content/out-pocket-surprise-costs-after-health-reform
Meghan Hoyer: "Will the Silver Tsunami Send Medicare into the Red?" 12.17.15reportingonhealth
Meghan Hoyer's slides from the Center for Health Journalism webinar "Will the Silver Tsunami Send Medicare into the Red?" 12.17.15
http://www.centerforhealthjournalism.org/content/will-silver-tsunami-send-medicare-red
Dr. Robert Berenson: "Does ‘Pay for Performance’ Work?" 6.28.16reportingonhealth
Dr. Robert Berenson's slides from the Center for Health Journalism webinar "Does ‘Pay for Performance’ Work?" 6.28.16
http://www.centerforhealthjournalism.org/content/does-pay-performance-work
PYA Principal Scott Clay presented “Pacing Volume-to-Value Transition” at the AlaHA Annual Meeting, June 8-11, 2016.
The presentation explored volume- to value-based reimbursement, and how the pace of change is unique to each organization. The presentation introduced a strategic framework to establish and communicate a pace of change befitting various organizations, explaining:
How government policies “set the floor” on the degree of change requested.
How to determine the pace of change in your market.
How to identify your organization’s current position and culture in relation to value-based payment models.
How to set and communicate the pace of transition consistent with your market and your organization’s culture.
The Vicissitudes of Valuing Value--Legal and Valuation Issues Associated with...PYA, P.C.
PYA Principal Carol Carden co-presented “The Vicissitudes of Valuing Value--Legal and Valuation Issues Associated with Value-Based Payment Models” at the 2017 American Health Lawyers Association Physician and Hospitals Law Institute, February 1-3, 2017, in Orlando, Florida.
The presentation addressed:
Emerging alternative payment models (APMs)
The application of fraud and abuse laws and IRS rules to provider network payments
Existing market data and regulatory guidance
Considerations in determining fair market value and commercial reasonableness
The Changing Healthcare System and Impact of MACRAPYA, P.C.
PYA Principal Lori Foley and Consulting Senior Aaron Elias co-presented “The Changing Healthcare System and Impact of MACRA” at the Physician Insurers Association of America’s CEO/COO Meeting.
The Medicare Access & CHIP Reauthorization Act (MACRA) dramatically affected Medicare reimbursements to healthcare providers, as well as provided a new framework for rewarding quality care and reporting on quality measurements. This incentive-based system has the potential not only to change how medicine is practiced, but influence patient perception of care. The presentation will provide the latest information on MACRA implementation, and will detail how the aforementioned changes will impact miscellaneous professional liability insurers.
Deployment of the Medicare Access and CHIP Reauthorization ActPYA, P.C.
PYA Principal Martie Ross and Senior Manager Graham Fox presented, “Mastering MIPS" at the American College of Healthcare Executives’ Congress on Healthcare Leadership.
Learning objectives included:
Gaining an understanding of MIPS—why it was implemented and how it will impact reimbursement, governance, and strategic planning for healthcare organizations.
Identifying questions organizations must consider during MIPS implementation that will lead to financial and operational success.
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyWes Chapman
Transitioning to value based care in medical oncology is a major strategic change in any medical practice. In this presentation to Grand Rounds at the Norris Cotton Cancer Center at Dartmouth, we look at the strategic and operational considerations of making such a transition effective.
Dr. Robert Berenson: "Does ‘Pay for Performance’ Work?" 6.28.16reportingonhealth
Dr. Robert Berenson's slides from the Center for Health Journalism webinar "Does ‘Pay for Performance’ Work?" 6.28.16
http://www.centerforhealthjournalism.org/content/does-pay-performance-work
PYA Principal Scott Clay presented “Pacing Volume-to-Value Transition” at the AlaHA Annual Meeting, June 8-11, 2016.
The presentation explored volume- to value-based reimbursement, and how the pace of change is unique to each organization. The presentation introduced a strategic framework to establish and communicate a pace of change befitting various organizations, explaining:
How government policies “set the floor” on the degree of change requested.
How to determine the pace of change in your market.
How to identify your organization’s current position and culture in relation to value-based payment models.
How to set and communicate the pace of transition consistent with your market and your organization’s culture.
The Vicissitudes of Valuing Value--Legal and Valuation Issues Associated with...PYA, P.C.
PYA Principal Carol Carden co-presented “The Vicissitudes of Valuing Value--Legal and Valuation Issues Associated with Value-Based Payment Models” at the 2017 American Health Lawyers Association Physician and Hospitals Law Institute, February 1-3, 2017, in Orlando, Florida.
The presentation addressed:
Emerging alternative payment models (APMs)
The application of fraud and abuse laws and IRS rules to provider network payments
Existing market data and regulatory guidance
Considerations in determining fair market value and commercial reasonableness
The Changing Healthcare System and Impact of MACRAPYA, P.C.
PYA Principal Lori Foley and Consulting Senior Aaron Elias co-presented “The Changing Healthcare System and Impact of MACRA” at the Physician Insurers Association of America’s CEO/COO Meeting.
The Medicare Access & CHIP Reauthorization Act (MACRA) dramatically affected Medicare reimbursements to healthcare providers, as well as provided a new framework for rewarding quality care and reporting on quality measurements. This incentive-based system has the potential not only to change how medicine is practiced, but influence patient perception of care. The presentation will provide the latest information on MACRA implementation, and will detail how the aforementioned changes will impact miscellaneous professional liability insurers.
Deployment of the Medicare Access and CHIP Reauthorization ActPYA, P.C.
PYA Principal Martie Ross and Senior Manager Graham Fox presented, “Mastering MIPS" at the American College of Healthcare Executives’ Congress on Healthcare Leadership.
Learning objectives included:
Gaining an understanding of MIPS—why it was implemented and how it will impact reimbursement, governance, and strategic planning for healthcare organizations.
Identifying questions organizations must consider during MIPS implementation that will lead to financial and operational success.
Transitioning to Value Based Care: Tennessee Oncology, A Case StudyWes Chapman
Transitioning to value based care in medical oncology is a major strategic change in any medical practice. In this presentation to Grand Rounds at the Norris Cotton Cancer Center at Dartmouth, we look at the strategic and operational considerations of making such a transition effective.
Healthcare Consumerism and Cost: Dispelling the Myth of Price TransparencyHealth Catalyst
The world of healthcare costs is confusing and messy for both patients and providers. Many providers don’t fully understand their costs and therefore struggle to meet the increasing pressure for greater price transparency for consumers. With price transparency rules finalized and implementation looming, many providers are racing against the clock to adapt business practices to meet regulations and communicate the implications to consumers. And each organization’s financial health depends on transparency, as uncertainty about costs keeps many patients from seeking care.
Deb Gordon, seasoned healthcare executive and author of the book, “The Health Care Consumer’s Manifesto: How to Get the Most for Your Money,” and Pat Rocap, Director of Cost Management Services at Health Catalyst, examine the relationship between cost and pricing as the path to transparency for consumers. Deb and Pat provide expert analysis and practical advice to help you become a savvier provider and consumer when it comes to healthcare pricing and spending.
- The implications of federal price transparency regulations.
- The connection between healthcare costing and pricing.
- How to start your organization’s journey to understand costs and why it matters.
- Why price transparency is important to both patients and providers.
Healthcare Billing and Reimbursement: Starting from ScratchDale Sanders
The healthcare billing environment in the US is a disaster. It creates huge waste in care and cost. As presented at the Cayman Islands International Healthcare Conference in October 2010, this slide deck suggests what the billing system might look like, if we could start over.
Cypress Benefit Administrators is a full service Third Party Administration (TPA) company. We specialize in helping companies outsource Flexible Spending Accounts (Section 125), HRA, HSA, and COBRA. Additionally, we provide expertise in self-funded medical plan administration.
WealthTrust-Arizona - Five Fallacies for Improving Healthcare WealthTrust-Arizona
Educational workshop presented by WealthTrust-Arizona and world-renowned guest Robert K. Smoldt, Chief Administrative Officer Emeritus at Mayo Clinic and Associate Director of Healthcare Delivery & Policy Programs at Arizona State University. Mr. Smoldt has been involved in health care administration for more than 30 years and is currently pursuing U.S. health reform in close partnership with Mayo Clinic’s Emeritus President and CEO.
At this workshop Robert examines a number of general statements that are, in his view, fallacious.
Prof. Martin Gaynorin esitys VATT-päivässä 1.11.2016
Gaynor on professori Carnegie Mellon yliopistossa, tutkija Britannian johtavassa, julkisen sektorin reformeihin keskittyvässä tutkimuslaitoksessa (Bristolin yliopiston Centre for Market and Public Organisation) ja jäsenenä NHS:n kilpailuasioita käsittelevässä asiantuntijapaneelissa.
Gaynor on tehnyt vaikutusvaltaisia tutkimuksia ja kirjoittanut laajasti terveydenhuoltomarkkinoiden toiminnasta, kilpailusta, kilpailua rajoittavista tekijöistä, tuottajien saamista korvauksista sekä Yhdysvalloissa että Briteissä.
Why Hospitals Want Patients to Pay UpfrontBy John Tozzi Septem.docxalanfhall8953
Why Hospitals Want Patients to Pay Upfront
By John Tozzi September 25, 2014
Tozzi is a reporter for Bloomberg Businessweek in New York.
URL: http://www.businessweek.com/articles/2014-09-25/why-hospitals-want-patients-to-pay-upfront
Melody Rempe spends much of her day telling people who are about to go into the hospital how much they’ll have to pay. As a patient financial counselor at Nebraska Methodist Health System, she calls patients about a week before they go in for procedures with estimates of their bills and what portion insurance will cover. Although many are grateful, some cry or yell. “Sometimes you’re talking to them about the biggest thing in their life,” she says. Rempe says most calls end well when she walks patients through the hospital’s payment-plan options or other financial assistance.
Hospitals have good reason to be concerned about their patients’ finances: Even people with insurance are increasingly responsible for a big portion of their medical bills. Among Americans who get health coverage at work, 41 percent have deductibles of at least $1,000 they must meet before insurance starts paying. That’s up from 10 percent in 2006, according to the Kaiser Family Foundation. Those with employer coverage are joined by 7 million new enrollees in Obamacare plans, which typically make patients share a large chunk of costs. The average deductible in the most popular “silver” tier of coverage is $2,267, according to an analysis by the Robert Wood Johnson Foundation.
Raising deductibles helps employers and insurers limit premium hikes. It also shifts more of the risk onto individuals. That in turn boosts the chances that doctors and hospitals won’t get paid. If a patient has a $2,900 deductible, “it’s far more difficult to get that $2,900 from an individual patient than it is from the Medicare program or from Blue Cross Blue Shield,” says Richard Gundling, vice president of the Healthcare Financial Management Association, a trade group. A March report on hospitals from Moody’s (MCO), the credit-rating firm, was blunt: “Today’s high deductibles are tomorrow’s bad debt.”
Hospitals’ total cost of uncompensated care reached $46 billion in 2012, equal to about 6 percent of their expenses, the American Hospital Association says. Large for-profit chains such as LifePoint Hospitals (LPNT), which operates more than 60 medical centers in 20 states, have felt the impact of rising deductibles. LifePoint’s bad debt related to copays and deductibles is running at $25 million per quarter this year, up from $15 million per quarter in 2013, Leif Murphy, the company’s chief financial officer, said on an earnings call in July. He blamed the increase in part on the growing prevalence of high-deductible plans.
As the mechanics of insurance policies become more complicated, Americans are having a harder time understanding how their plan choices will affect their finances. Only 14 percent of insured adults correctly understand insurance jargon such as de.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
1. The Next Right Thing for Health Plans
Metric Based Pricing:
Myths and Keys to Success
Wednesday, October 5, 2016
2. Founded in 2003, ELAP Services is a pioneer in health plan cost management that
delivers an industry-best comprehensive solution for self funded employers –
the only that provides:
ELAP Overview
PLAN DESIGN &
CO-FIDUCIARY
CLAIMS AUDIT
DIRECT
CONTRACT
MEMBER
ADVOCACY AND
DEFENSE
ANALYTICS
3. How metric-based
pricing addresses
the root of the
problem
Why MBP?
5 common myths
about metric-
based pricing
Myths
The 3 keys to a
successful MBP
program
Success
Agenda
The unsustainable
‘status quo’ of a
PPO system
The Problem
4. “All the Prices are too damn high”
- Gerard F. Anderson, Johns Hopkins Bloomberg
School of Public Health
Inflated Medical Bills: The Root of the Healthcare Problem
“Getting a 50% or even 60% discount off the
chargemaster price of an item that costs $13 and lists for
$199.50 is still no bargain.”
-Steven Brill, TIME Magazine
“American Employers are the sloppiest purchasers of health
care anywhere in the world…they have passively paid just
about every health care bill that has been put before them,
with few questions asked.”
– Uwe Reinhardt, Princeton Professor
5. A Managed Care Issue or an Economic Debate?
“The health plan fiduciary is typically
oblivious to the true costs hidden
inside their plans in the same way
they don’t understand the all-in costs
of their 401(k) plan.
The major difference is that
healthcare waste can easily be ten
times greater than the “Bps” being
scrutinized inside 401(k) plans.”
- Craig Lack, Benefits Expert
6. SOURCE: Kaiser/HRET Survey of Employer‐Sponsored Health Benefits, 1999‐2015
Healthcare Cost Impact on Members and Their Families
• 40% of Americans
have medical debt
and 1 in 5 have
credit impairments
– most are fully
insured
7. In Eastern Pennsylvania, What Does a Plan Pay for……a CT Scan?
Departmental statistics are obtained from a hospital's most recent Medicare cost report data, from American Hospital Directory – www.ahd.com
$2,892
$1,446
$199
$145
$0 $500 $1,000 $1,500 $2,000 $2,500 $3,000 $3,500
Hospital Cost Medicare Payment 50% PPO Discount Billed Charges
8. How metric-based
pricing addresses
the root of the
problem
Why MBP?
5 common myths
about metric-
based pricing
Myths
The 3 keys to a
successful MBP
program
Success
Agenda
The unsustainable
‘status quo’ of a
PPO system
The Problem
9. Higher Discount = Worse Deal?
*Study using ELAP data for each state
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
70.0%
80.0%
0% 50% 100% 150% 200% 250% 300%
Savings%
% of Medicare
% Savings off Billed vs. % of Medicare
Direct correlation between
higher discounts and higher
payment as multiple of
Medicare
10. What is Metric-Based Pricing?
Metric-based pricing uses rational and consistent
metrics, Medicare and cost, as a starting point for
provider reimbursement – rather than the discount
set by the carriers and insurance companies
11. Why Metric Based Pricing?
We give our clients the opportunity to treat
their medical costs in the same manner that
they would any other business cost
Simply Stated…
12. How metric-based
pricing addresses
the root of the
problem
Why MBP?
5 common myths
about metric-
based pricing
Myths
The 3 keys to a
successful MBP
program
Success
Agenda
The unsustainable
‘status quo’ of a
PPO system
The Problem
14. Reference Based Pricing vs. Metric Based Pricing
Hospital CHospital BHospital A
CT Scan
$400
• Medicare and cost can vary greatly from hospital to hospital
• Non-specific reimbursement methods weaken legal position
• Only pricing one way is unfair to providers
Reference-Based Methodology: CT Scan
$400 $400
15. Reference Based Pricing vs. Metric Based Pricing
Metric-Based Methodology
Hospital CHospital BHospital A
$352
$348
$248
$302
$458
$485
• Look at specific hospital’s specific costs and Medicare rates for each line on bill
• Re-priced two ways and paid at higher rate to ensure fair payment
• Paid exactly as plan document states – strong legal position (specific, current, attested by CFO)
CT Scan
17. Is Medicare a fair baseline?
• Do Hospitals make money on Medicare?
• Studies vary:
• Anywhere from -9.0% margin to +1.5% profit margin on Medicare payments
• Nearly 50% of Hospitals make money on Medicare
$80
$85
$90
$95
$100
$105
$110
Hospital All-In
Cost
Medicare
Payment
Metric-Based
Payment
• Even at worst case (-9.0%) and a very low metric-based reimbursement (Med +20%) – hospital
makes profit
19. Credit Impairments Due to HC Costs
“62% of US bankruptcies are related to medical bills, 75% of those filing for bankruptcy were fully insured.”
- Medical Bankruptcy in the United States… a study by Harvard University (2007)
“Bankruptcies resulting from unpaid medical bills will affect nearly 2 million people this year—making
health care the No. 1 cause of such filings” – CNBC (2013)
“Mounting evidence shows that chaos in medical billing is not just affecting our health care but dinging the financial
reputation of many Americans… the credit record of one in five Americans is affected”
… unpaid medical bills in collection “frequently end up on consumer credit reports,” as an outgrowth of “very complex
and confusing systems of figuring out who owes what after a medical procedure.”
- When Health Costs Harm Your Credit, The New York Times (2014)
20. Metric-Based Pricing Reduces Change of Hitting Full OOP
W/PPO
(45% disc)
Billed Charges $10,000
Total Allowed/Paid $5,500
Member Deductible $5,000
Member Paid $5,000
Plan Paid $500
Total Paid $5,500
W/MBP
(62% disc)
$10,000
$3,800
$5,000
$3,800
$0
$3,800
Scenario: $10,000 Billed Charges for Hospital Visit
Savings
$1,200
$500
$1,700
22. Provider Pushback
Providers accept MBP patients the vast majority of
time
1
In rare cases, providers will demand payment up front for
a planned procedure (colonoscopy / mammogram) --- in
those cases a single-patient contract can be negotiated so
member receives proper care3
Most common forms of pushback
occur after bill is paid – appeal and
balance bill 2
24. Not if it’s done right…
Negotiating payment any time there is pushback
leads to cost uncertainty, stop/loss issues and
encourages providers to increase pushback1
Current PPO model with annual increase in health
care spend is not sustainable
3
ELAP has clients w/ 9+ years on
full audit program with little to no
increase in spend year over year 2
Hold the line
Consistent Savings
Status Quo ineffective
25. How metric-based
pricing addresses
the root of the
problem
Why MBP?
5 common myths
about metric-
based pricing
Myths
The 3 keys to a
successful MBP
program
Success
Agenda
The unsustainable
‘status quo’ of a
PPO system
The Problem
30. Indicators of a good MBP fit
• Self-funded, 150+ enrolled employees
• High health care costs / high renewal increase
• Engaged executives / innovative mindset
• Organization with tight budgets, or low margins